The Juvenile Diabetes Research Foundation, a leader in type 1 diabetes research worldwide, has named Jeffrey Brewer their new President and Chief Executive Officer.
Brewer, an entrepreneur and philanthropist, has been a passionate JDRF volunteer and donor for the past eight years, playing a key leadership role in the organization’s research activities. He became involved with JDRF since soon after his son, Sean, was diagnosed with type 1 diabetes in 2002. He has served as a director of JDRF’s international board since 2004, is a reviewer on JDRF’s Lay Review Committee (which judges the potential of diabetes research from the perspective of people impacted by diabetes), and has been an active member and donor for the foundation’s New York Chapter.
“Jeffrey Brewer has all the qualities we were looking for in a leader for JDRF: experience in managing large and growing organizations, a detailed understanding of diabetes research, and a track record of success,” said Frank Ingrassia, Chairman of the JDRF Board of Directors. “When you add to that a drive and passion for finding a cure, based on his own family experience with diabetes and the people around the world he has met in his years as a volunteer with JDRF, that’s a terrific combination to help us speed progress towards the cure.”
As a JDRF volunteer, he has been particularly involved in leading the organization’s Artificial Pancreas Project, which over the past four years has significantly accelerated both academic and industry research leading to the development of automated systems to better control diabetes in children, teens, and adults. In addition to improving the lives of people with type 1 diabetes, the improved control that these systems can provide will lower the risk of dangerous low-blood sugar emergencies, reduce the risk of long-term complications, and potentially improve the efficacy of cures and treatments as they become available.
“As a volunteer, it is so humbling and rewarding to work side by side with our passionate volunteers and our impressive staff in our collective effort to advance the pace of research leading to better treatments and cures for people with diabetes,” Mr. Brewer said. “I feel we are on the cusp of exciting research progress that can make a real difference in the lives of people living with this terrible disease – including some tangible advances delivered to patients in the not-too-distant future. I’m honored to become a full-time part of driving us towards our goals, and helping us translate research into drugs and devices that will help people with type 1 diabetes live better, longer and healthier, and ultimately to remove this disease from people’s lives forever.”
Contact your St. Louis Diabetes Examiner:
[email protected] | TuDiabetes.com | Juvenation.org | Twitter.com
Click “Subscribe to Email” below to receive alerts when new articles about diabetes are posted. Your address will not be shared with anyone.